You have 9 free searches left this month | for more free features.

SARS-CoV-2 Vaccine

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

SARS-CoV-2 Infection, Varicella, Measles Trial in Shanghai (Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine,

Not yet recruiting
  • SARS-CoV-2 Infection
  • +4 more
  • Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Municipal Center for Disease Control and Prevention
Jul 17, 2023

SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Recombinant SARS-CoV-2 vaccine, Saline)

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA Vaccine
  • +2 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023

COVID-19 Trial in Guangzhou (the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine)

Recruiting
  • COVID-19
  • the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine
  • Guangzhou, Guangzhou, China
    The Fifth Affiliated Hospital of Guangzhou Medical University
Jan 28, 2023

SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Saline)

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA Vaccine
  • Saline
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023

SARS-CoV-2 Vaccine in Metabolism-related Fatty Liver Disease

Not yet recruiting
  • Metabolic Associated Fatty Liver Disease
  • Recombinant protein vaccine and adenovirus vector vaccine
  • (no location specified)
Feb 12, 2023

Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in

Active, not recruiting
  • SARS-CoV-2 RNA Vaccines
  • HIV Infection
  • SARS-CoV-2 Vaccine
  • Sevilla, Spain
    Virgen del Rocio University Hospital
Dec 1, 2022

COVID-19 Trial in Shang Qiu (low-dose Recombinant SARS-CoV-2 Vaccine (CHO cell), high-dose Recombinant SARS-CoV-2 Vaccine (CHO

Active, not recruiting
  • COVID-19
  • low-dose Recombinant SARS-CoV-2 Vaccine (CHO cell)
  • +2 more
  • Shang Qiu, He Nan, China
    Ning ling Center for Disease Control and Prevention
Jan 31, 2023

COVID-19, Vaccine Reaction Trial in Chengdu (LYB001, CoronaVac)

Active, not recruiting
  • COVID-19
  • Vaccine Reaction
  • LYB001
  • CoronaVac
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital Affiliated to North Sichuan Medical Coll
Jun 29, 2023

Vaccine Reaction Trial in Venice-Lido (blood sample collection)

Active, not recruiting
  • Vaccine Reaction
  • blood sample collection
  • Venice-Lido, Italy
    IRCCS San Camillo
Aug 24, 2022

SARS-CoV-2, Safety, Immunotoxicity Trial in Wuhan (one dose of the study SARS-CoV-2 mRNA Vaccine (SYS6006), Cellular Immunity,

Not yet recruiting
  • SARS-CoV-2
  • +2 more
  • one dose of the study SARS-CoV-2 mRNA Vaccine (SYS6006)
  • +3 more
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Aug 9, 2022

COVID-19 Trial in Nanjing (Recombinant SARS-CoV-2 Ad5 vectored vaccine, Inactive SARS-CoV-2 vaccine (Vero cell))

Completed
  • COVID-19
  • Recombinant SARS-CoV-2 Ad5 vectored vaccine
  • Inactive SARS-CoV-2 vaccine (Vero cell)
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Mar 28, 2022

COVID-19, SARS-CoV-2 Trial in Seoul (QTP104 1ug, QTP104 5ug, QTP104 25ug)

Active, not recruiting
  • COVID-19
  • SARS-CoV-2
  • QTP104 1ug
  • +2 more
  • Seoul, Korea, Republic of
  • +1 more
May 24, 2023

COVID-19 Trial in Shijiazhuang (SARS-CoV-2 Inactivated Vaccine, Placebo)

Completed
  • COVID-19
  • SARS-CoV-2 Inactivated Vaccine
  • Placebo
  • Shijiazhuang, Hebei, China
    Zanhuang county Center for Disease Control and Prevention
Aug 10, 2022

Chronic Lymphocytic Leukemia, COVID-19 Infection Trial in Duarte (Biospecimen Collection, mRNA COVID-19 Vaccine, Synthetic

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • COVID-19 Infection
  • Biospecimen Collection
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jan 3, 2023

COVID-19 Trial in Wuhan (Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001, ZF2001)

Active, not recruiting
  • COVID-19
  • Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001
  • ZF2001
  • Wuhan, Hubei, China
    Hubei Provincial Center for Disease Control and Prevention
Jan 12, 2023

COVID-19 Trial in Chengdu (LYB002V14, LYB002V14A, LYB002CA)

Active, not recruiting
  • COVID-19
  • LYB002V14
  • +2 more
  • Chengdu, Sichuan, China
    Affiliated Hospital of North Sichuan MedicalCollege
Jun 29, 2023

COVID-19 Pneumonia, COVID-19 Trial in Abu Dhabi (SARS-CoV-2 Vaccine (Vero Cell), Inactivated)

Recruiting
  • COVID-19 Pneumonia
  • COVID-19
  • SARS-CoV-2 Vaccine (Vero Cell), Inactivated
  • Abu Dhabi, United Arab Emirates
    Sheikh Khalifa Medical City, SEHA
Jul 10, 2022

Coadministration of Influenza Vaccination With Booster Dose of

Completed
  • Co-administration of COVID-19 and Influenza Vaccines
  • COMIRNATY
  • Roma, RM, Italy
    Fondazione Policlinico Gemelli
Mar 10, 2023

Covid19 Trial in Cypress (VXA-CoV2-1)

Completed
  • Covid19
  • VXA-CoV2-1
  • Cypress, California
    WCCT
Jan 17, 2023

Covid-19 Vaccine Trial (PIKA COVID-19 vaccine)

Not yet recruiting
  • Covid-19 Vaccine
  • PIKA COVID-19 vaccine
  • (no location specified)
Jul 17, 2022

SARS-CoV-2 Trial in Islamabad (LVRNA009, CoronaVac®)

Not yet recruiting
  • SARS-CoV-2
  • LVRNA009
  • CoronaVac®
  • Islamabad, Pakistan
    Clinical Trial Unit, National Institute of Health
Jun 22, 2022

COVID-19 Trial in Xuzhou (Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the emergency vaccination schedule, Two

Completed
  • COVID-19
  • Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the emergency vaccination schedule
  • +11 more
  • Xuzhou, Jiangsu, China
    Suining County Center for Disease Control and Prevention
Feb 22, 2022

SARS-CoV2 Infection Trial in Renton (HDT-301)

Active, not recruiting
  • SARS-CoV2 Infection
  • HDT-301
  • Renton, Washington
    Rainier Clinical Research
Jan 16, 2023

Effectiveness of the COVID-19 Inactivated Vaccine

Active, not recruiting
  • COVID-19
  • SARS-CoV-2 vaccine (Vero cell) inactivated
  • Bandung, Indonesia
  • +3 more
Sep 4, 2022

Antibody Detection of Vaccine-Induced Secretory Effects

Active, not recruiting
  • Covid19
  • +3 more
  • SARS-CoV-2 vaccine
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Jul 18, 2022